Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Adenosine and Glucagon

supplement:

Adenosine

Research Papers that Mention the Interaction

ABSTRACT The glycemic response to glucagon is activated via hepatic adenosine 3′,5′-monophosphate (cyclic AMP), and the subsequent urinary cyclic AMP response to glucagon has previously been found to be of hepatic origin.
The Journal of clinical endocrinology and metabolism  •  1974  |  View Paper
Though exogenous application of adenosine has been demonstrated to stimulate glucagon release and inhibit insulin release, the physiological significance of this pathway has been unclear.
Islets  •  2012  |  View Paper
Vasomodulation resulted in significant decreases in normalized tumor perfusion ratio: 66.22% ± 24.57 (P < .01) with glucagon, 71.45% ± 22.72 (P < .01) with adenosine, and 74.98% ± 16.58 (P < .01) with glucagon plus adenosine.
Journal of vascular and interventional radiology : JVIR  •  2012  |  View Paper
Adenosine also inhibited glucagon release while ATP was stimulatory.
Diabetologia  •  2004  |  View Paper
Adenosine inhibited the glucagon mediated increase in cAMP.
Life sciences  •  1991  |  View Paper
Superimposition of glucagon to adenosine caused further vasodilation, and the autoregulatory efficiency was completely attenuated.
Japanese journal of pharmacology  •  1990  |  View Paper
Previous studies have shown that adenosine , by activation of purinergic A2-receptors, stimulates glucagon secretion and increases vascular flow rate in isolated perfused pancreases from nondiabetic rats.
Whereas, in normal rats, adenosine (1.65 μM) induced a 200% increase in glucagon output and a 25% rise in the pancreatic vascular flow rate, in rats diabetic for 5–6 wk, this nucleoside was ineffective on glucagon secretion, and its vasodilatory effect was strongly reduced.
Diabetes  •  1989  |  View Paper
Previous studies from our … showed 1) that adenosine (1.65 microM), a substance released by tissues in energy-deficient states, stimulated glucagon secretion by activation of A2 purinergic receptors, and 2) that this effect was potentiated by a low substimulating concentration of epinephrine through activation of alpha-adrenergic receptors.
Endocrinology  •  1987  |  View Paper
In vivo adenosine administration altered the secretion of hormones by the islets of Langerhans (increased the release of glucagon and decreased the secretion of insulin) but this was only clearly observable under stimulated conditions.
The International journal of biochemistry  •  1987  |  View Paper
Conversely, upon removal of adenosine , addition of Rs ligands such as isoproterenol, adrenocorticotropic hormone, or glucagon strongly inhibited transport (approximately 50%) and stimulated kinase activity.
The Journal of biological chemistry  •  1987  |  View Paper
Show More